Mark Avagliano is Chief Business Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 244,683 shares of GTHX, which is worth approximately $628,835. The most recent transaction as insider was on Jul 01, 2024, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 245K
12.33% 3M change
217.13% 12M change
Total Value Held $628,835

Mark Avagliano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
35,000 Added 12.51%
244,683 Common Stock
May 13 2024
SELL
Open market or private sale
$39,043 $4.79 p/Share
8,151 Reduced 3.74%
209,683 Common Stock
Mar 20 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 31.46%
217,834 Common Stock
Jan 04 2024
SELL
Open market or private sale
$2,119 $2.94 p/Share
721 Reduced 0.61%
117,834 Common Stock
Jan 03 2024
SELL
Open market or private sale
$10,483 $3.12 p/Share
3,360 Reduced 2.76%
118,555 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
44,760 Added 26.85%
121,915 Common Stock
May 10 2023
BUY
Grant, award, or other acquisition
-
35,000 Added 31.21%
77,155 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
20,600 Added 32.83%
42,155 Common Stock
Jan 05 2022
SELL
Open market or private sale
$15,331 $10.61 p/Share
1,445 Reduced 6.28%
21,555 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 34.29%
23,000 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 50.0%
11,000 Common Stock
MA

Mark Avagliano

Chief Business Officer
Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Track Activities on GTHX